Companies

See how salaries can vary from company to company

American BriVision (Holding) Corporation, a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV- 1501, a combination therapy for triple negative breast cancer; ABV-1504 for major depressive disorders; ABV-1505 for attention deficit hyperactivity disorder and maitake combination therapy; ABV-1703 for the treatment of pancreatic cancer; ABV-1702 to treat myelodysplastic syndromes; and ABV-1601 for treating depression in cancer patients. It has a co-development agreement with Rgene Corporat... view company details

ArQule, Inc., a biopharmaceutical company, researches and develops therapeutics for the treatment of cancer and rare diseases in the United States. The company's pipeline includes ARQ 531, an orally bioavailable, potent and reversible dual inhibitor of wild type and C481S-mutant Bruton's tyrosine kinase that is in Phase I trial for patients with B-cell malignancies refractory to other therapeutic options; and miransertib (ARQ 092), a potent and selective inhibitor of the protein kinase B (AKT), a serine/threonine kinase, which is in Phase Ib in combination with the hormonal therapy and anastro... view company details

ASGN Incorporated provides information technology (IT) and professional staffing services in the technology, digital, creative, engineering, and life sciences fields across commercial and government sectors in the United States and internationally. The company operates through Apex, Oxford, and ECS segments. The Apex segment offers technical, scientific, digital, and creative services and solutions for contract, contract-to-hire, and permanent placement positions to Fortune 1000 and mid-market clients. The Oxford segment provides specialized staffing and permanent placement services in the are... view company details

Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Selincro, an orally administered drug for the treatment of alcohol dependence in Europe. It also markets Ampyra as Fampyra in Europe, Asia, and the Americas. In addition, the company develops Inbrija for the treatment of OFF periods in Parkinson's disease; an inhaled triptan (zolmitriptan) for acute treatment of migraine by using the... view company details

AeroGrow International, Inc. engages in the development, marketing, direct-selling, and wholesale of indoor garden systems to consumers and retailers in the United States, Canada, and various countries in Europe. The company's principal products include indoor gardens and proprietary seed pod kits that allow consumers to grow vegetables, such as tomatoes, chili peppers, and salad greens; fresh herbs comprising cilantro, chives, basil, dill, oregano, and mint; and flowers, which comprise petunias, snapdragons, geraniums, and vinca. It also provides grow lights and a patented nutrient formula, a... view company details

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops cell and gene therapies for life-threatening rare genetic diseases. Its lead programs include EB-101, an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa; ABO-102, an adeno-associated virus-based gene therapy for Sanfilippo syndrome type A; and ABO-101 an AAV-based gene therapy for Sanfilippo syndrome type B. The company also develops ABO-202 and ABO-201, which are AAV-based gene therapies for the CLN1 and CLN3 forms of Batten disease; ABO-401 for the treatment of cystic fibrosi... view company details

Advanzeon Solutions, Inc. provides managed care services in the behavioral health, substance abuse, and pharmacy management fields in 47 states, the District of Columbia, and Puerto Rico. The company's managed care operations include administrative service agreements, fee-for-service agreements, and capitation contracts. Its programs and services comprise integrated behavioral healthcare and pharmacy management services; management of prescription drugs on an at-risk basis; analytic services for medical and pharmacy claims; case management/utilization review services; administrative services m... view company details

Avnet, Inc., a technology solutions company, distributes electronic components worldwide. The company operates through two segments, Electronic Components and Premier Farnell. The Electronic Components segment markets and sells semiconductors; electronic components, including interconnect, passive, and electromechanical devices; and other integrated components from electronic component manufacturers. It also offers design chain support that provides engineers with technical design solutions; engineering and technical resources to support product design, bill of materials development, and techn... view company details

A New Leaf's mission is helping families, changing lives. We work for the independence of individuals and families, served through our domestic violence shelters, homeless programs, youth development and community services. A New Leaf accomplishes its mission by building a community for self-reliance, teaching life skills, sharing tools, and partnering with stakeholders. We provide housing solutions, foster care, financial counseling, community outreach, youth support, and individual and family residential services -- a total of 30+ programs across the Phoenix metro area. And we deliver these ... view company details

Achieving True Self provides treatment and consultation services to individuals, families and their surrounding communities (schools, organizations) impacted by one or more behavioral health diagnoses, including those affected by an autism spectrum disorder in Maryland, Pennsylvania and West Virginia. Our team takes pride in creating innovative plans grounded in evidence-based practice in order to help people of all ages achieve their unique goals. We recognize that each and every person's journey is different, and therefore our approach to treatment capitalizes on a person's strengths and des... view company details

The American Arbitration Association® (AAA®), with its long history and experience in the field of alternative dispute resolution, provides services to individuals and organizations who wish to resolve conflicts out of court. The AAA role in the dispute resolution process is to administer cases, from filing to closing. The AAA provides administrative services in the U.S., as well as abroad through its International Centre for Dispute Resolution® (ICDR®). The AAA's and ICDR's administrative services include assisting in the appointment of mediators and arbitrators, setting hearings, and providi... view company details

Anton Paar GmbH, founded in 1922 as a one-man locksmith‘s workshop, today is a globally active high-tech company headquartered in Graz, Austria with 29 sales and service subsidiaries worldwide. The company currently counts 2900 employees. Anton Paar develops and produces high-precision laboratory instruments as well as process measurement technology and provides custom-tailored automation and robotics solutions. A love of research and high quality standards have made Anton Paar a world market leader in the fields of density measurement, the determination of dissolved CO2, rheometry, material c... view company details

Founded in 1976, Apple Rehab, a diversified health care company specializing in the delivery of sub-acute and long term care services is one of the largest privately-owned companies in New England. In 1988, Apple was named on Inc. Magazine's list of the fastest-growing, privately-owned companies in the country. In 1995 Consumer Reports rated Apple as the best for-profit long term care company in America. Today Apple Rehab is best known as an innovative leader in short term rehabilitation and long term living services. Headquartered in Avon, Connecticut, Apple Rehab owns and operates twenty-fiv... view company details

Bancorp 34, Inc. operates as the holding company for Bank 34 that offers various banking services to individuals and businesses in the United States. It accepts various deposit products, such as savings accounts, checking accounts, money market accounts, demand deposits, NOW accounts, and certificates of deposit, as well as commercial checking accounts and related services, including online cash management. The company also originates commercial real estate loans, multi-family real estate loans, commercial and industrial loans, construction and land development loans, one- to four-family resid... view company details

Boston Therapeutics, Inc., a pre-clinical and clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of carbohydrate-based therapeutic drugs and dietary supplements in the United States. Its lead pharmaceutical drug candidates include BTI-320, a non-systemic, carbohydrate-based compound that is in Phase IIb clinical trial to reduce post-meal elevation of blood glucose levels in Type 2 diabetic and pre diabetic patients; BTI-410, a peptide injectable compound that has completed Phase Ib clinical trials for type 1 immunosuppression therapy after kid... view company details

Bluegreen Vacations Corporation operates as a vacation ownership company in the United States. It operates through two segments, Sales of VOIs and Financing; and Resort Operations and Club Management. The company markets, sells, and manages vacation ownership interests (VOIs) in resorts that are developed or acquired by the company, or developed and owned by third parties. Its VOIs enable buyers to use resort accommodations through an annual or biennial allotment of points that can be used to stay at any 45 club resorts and 24 club associate resorts. The company also provides management servic... view company details

Blue Corona is an award-winning, analytical, inbound marketing and SEO company. We help businesses identify and eliminate ineffective advertising strategies and generate more leads and sales from the web. Blue Corona's clients range from local home service businesses to international manufacturers. Our specialties include: ad tracking, analytics, content marketing, conversion rate optimization, email marketing, inbound marketing, pay per click (PPC) advertising, SEO, social media, and web design and development. For more information, visit our website https://www.bluecorona.com and/or check ou... view company details

Our Work Blue Matter is a specialized management consulting firm, founded in San Francisco with offices in the US and Europe. We work with life sciences clients to address business issues across the company and product value chain. Our collaborations with bio-pharmaceutical industry leaders focus on providing the strategic insights necessary to create and achieve their visions. Our Story Blue Matter was born out of a vision to bring together a group of people that are passionate about applying consulting skills to help shape great ideas, products, and companies. Blue Matter is founded on the p... view company details

CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar, a selective agonist of peroxisome proliferator-activated receptor delta, which has completed Phase II clinical study for the treatment of primary biliary cholangitis, as well as patients with nonalcoholic steatohepatitis. The company also develops MBX-2982, a selective orally-active G protein-coupled receptor agonist that interacts with bioactive lipids known to stimulate glucose-dependent insu... view company details

Coherus BioSciences, Inc., a commercial-stage biotherapeutics company, focuses on the biosimilar market worldwide. It markets UDENYCA, a long-acting granulocyte-colony stimulating factor, which stimulates production of granulocytes in order to promote the body's ability to fight infections. The company sells UDENYCA in the United States. Its clinical-stage product candidates include immunology, anti-tumor necrosis factor biosimilar candidates, CHS-1420 for adalimumab and CHS-0214 for etanercept, which has completed Phase III clinical programs; ophthalmology biosimilar candidates, CHS-3351 for ... view company details